MagForce USA
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer (NCT05010759) | MagForce USA | 2021-11-30 |
Track MagForce USA automatically
Every clearance here is in the API, with alerts when new ones post.